Business Standard

AstraZeneca says could begin Covid-19 vaccine production early in 2021

AstraZeneca Mexico's head said that Phase III trials were expected to conclude by November or December

Coronavirus, vaccine, covid, drugs, Sepsivac, clinical trials
Premium

an agreement between Mexico and Argentina and pharmaceutical company AstraZeneca

Reuters Mexico City
Production of a Covid-19 vaccine under an agreement between the Mexican and Argentine governments and pharmaceutical company AstraZeneca could begin in the first quarter of 2021, an AstraZeneca executive said on Thursday.


Sylvia Varela, head of AstraZeneca Mexico, said at the Mexican president's daily news conference that Phase III trials were expected to conclude by November or December.


What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in